Michael Nicholas O'Hare, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Core Binding Factor Alpha 2 Subunit | 3 | 2021 | 350 | 0.950 |
Why?
|
| Furin | 1 | 2021 | 46 | 0.750 |
Why?
|
| Retinal Neoplasms | 2 | 2016 | 146 | 0.570 |
Why?
|
| Pulmonary Fibrosis | 1 | 2021 | 506 | 0.560 |
Why?
|
| Retinoblastoma | 2 | 2016 | 317 | 0.540 |
Why?
|
| Choroidal Neovascularization | 4 | 2020 | 357 | 0.510 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2016 | 153 | 0.250 |
Why?
|
| Lung | 1 | 2021 | 9985 | 0.200 |
Why?
|
| Bleomycin | 1 | 2021 | 495 | 0.170 |
Why?
|
| Apolipoprotein E3 | 1 | 2019 | 107 | 0.170 |
Why?
|
| Wet Macular Degeneration | 1 | 2020 | 162 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2019 | 173 | 0.150 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 18119 | 0.150 |
Why?
|
| Arterioles | 1 | 2018 | 250 | 0.150 |
Why?
|
| Cell Physiological Phenomena | 1 | 2018 | 150 | 0.140 |
Why?
|
| Retinopathy of Prematurity | 1 | 2020 | 432 | 0.130 |
Why?
|
| Simian virus 40 | 1 | 2016 | 291 | 0.130 |
Why?
|
| Presenilin-1 | 1 | 2019 | 659 | 0.130 |
Why?
|
| Cell Growth Processes | 1 | 2016 | 384 | 0.130 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 724 | 0.120 |
Why?
|
| Lymphoma, Follicular | 1 | 2018 | 453 | 0.120 |
Why?
|
| Retina | 3 | 2020 | 2635 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1477 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 1 | 2020 | 1332 | 0.100 |
Why?
|
| Retinal Vessels | 1 | 2018 | 836 | 0.100 |
Why?
|
| Neuroglia | 1 | 2018 | 944 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 3733 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 2 | 2015 | 2877 | 0.100 |
Why?
|
| Lymphoma, B-Cell | 1 | 2018 | 935 | 0.100 |
Why?
|
| Mice | 10 | 2021 | 81101 | 0.100 |
Why?
|
| Diabetic Retinopathy | 1 | 2020 | 1267 | 0.090 |
Why?
|
| Ischemia | 1 | 2020 | 1863 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2021 | 18940 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 22003 | 0.090 |
Why?
|
| Endothelial Cells | 2 | 2020 | 3533 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 2047 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1081 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 4342 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3664 | 0.080 |
Why?
|
| Animals | 11 | 2021 | 167768 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9518 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4902 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2020 | 3480 | 0.050 |
Why?
|
| Kinetin | 1 | 2019 | 22 | 0.040 |
Why?
|
| Apolipoprotein E2 | 1 | 2019 | 135 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8544 | 0.040 |
Why?
|
| Hindlimb | 1 | 2020 | 509 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2020 | 666 | 0.040 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2019 | 278 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1825 | 0.030 |
Why?
|
| Bruch Membrane | 1 | 2015 | 65 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2018 | 562 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1788 | 0.030 |
Why?
|
| Amyloid | 1 | 2019 | 841 | 0.030 |
Why?
|
| Female | 5 | 2021 | 390323 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1610 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 64378 | 0.030 |
Why?
|
| Male | 4 | 2021 | 358747 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2019 | 1694 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 826 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 2015 | 540 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 384 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2020 | 1343 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 2015 | 329 | 0.030 |
Why?
|
| Choroid | 1 | 2015 | 349 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 1893 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 802 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2129 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1751 | 0.020 |
Why?
|
| Pedigree | 1 | 2019 | 4578 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2020 | 4113 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 670 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 4567 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2018 | 5031 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2015 | 1044 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2970 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1969 | 0.020 |
Why?
|
| Cell Survival | 1 | 2019 | 5781 | 0.020 |
Why?
|
| Glucose | 1 | 2020 | 4336 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2018 | 3680 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5201 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2020 | 23342 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3816 | 0.020 |
Why?
|
| Mitochondria | 1 | 2018 | 3584 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11070 | 0.010 |
Why?
|
| Genotype | 1 | 2018 | 12945 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15591 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14354 | 0.010 |
Why?
|
| Cytokines | 1 | 2018 | 7338 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8506 | 0.010 |
Why?
|
| Humans | 7 | 2020 | 758406 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29557 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20055 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 29915 | 0.010 |
Why?
|
| Brain | 1 | 2019 | 26947 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 168218 | 0.000 |
Why?
|